Variant report
Variant | nsv874888 |
---|---|
Chromosome Location | chr2:113796666-113808054 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:113793052..113795716-chr2:113797814..113799974,2 | K562 | blood: | |
2 | chr2:113799300..113800125-chr2:113836934..113837726,3 | MCF-7 | breast: | |
3 | chr2:113793052..113795828-chr2:113797640..113799974,2 | K562 | blood: | |
4 | chr2:113756681..113759563-chr2:113795115..113796939,2 | K562 | blood: | |
5 | chr2:113798210..113800371-chr2:113830392..113832016,2 | MCF-7 | breast: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IL36RN-2 | chr2:113802726-113802812 | l_1927_chr2:113799151-113802812_thyroid |
2 | lnc-IL36RN-2 | chr2:113799365-113799600 | l_1927_chr2:113799151-113802812_thyroid |
3 | lnc-IL36RN-2 | chr2:113799152-113799363 | l_1927_chr2:113799151-113802812_thyroid |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1374280 | chr2:113796666-113796667 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs113819754 | chr2:113796673-113796674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573595269 | chr2:113796697-113796698 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79613977 | chr2:113796698-113796699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556306562 | chr2:113796704-113796705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76075666 | chr2:113796707-113796708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143757145 | chr2:113796740-113796741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564778732 | chr2:113796778-113796779 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188123999 | chr2:113796801-113796802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541020857 | chr2:113796837-113796838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561616229 | chr2:113796840-113796841 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376899039 | chr2:113796855-113796856 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547177788 | chr2:113796950-113796951 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530398068 | chr2:113796954-113796955 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554811096 | chr2:113796987-113796988 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191805528 | chr2:113797113-113797114 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570248337 | chr2:113797124-113797125 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143176485 | chr2:113797142-113797143 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533309491 | chr2:113797150-113797151 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552644362 | chr2:113797157-113797158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565825700 | chr2:113797172-113797173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534742889 | chr2:113797193-113797194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549828034 | chr2:113797242-113797243 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1446508 | chr2:113797261-113797262 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs184347153 | chr2:113797267-113797268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535087647 | chr2:113797284-113797285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189249733 | chr2:113797315-113797316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536561174 | chr2:113797362-113797363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556154094 | chr2:113797384-113797385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148263369 | chr2:113797423-113797424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2862773 | chr2:113797444-113797445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372807927 | chr2:113797445-113797446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs74997617 | chr2:113797446-113797447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34015028 | chr2:113797447-113797448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs3049662 | chr2:113797449-113797450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558662007 | chr2:113797464-113797465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572171644 | chr2:113797492-113797493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541057455 | chr2:113797537-113797538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1900287 | chr2:113797565-113797566 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs529680630 | chr2:113797595-113797596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112788078 | chr2:113797631-113797632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1900288 | chr2:113797645-113797646 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs2862774 | chr2:113797677-113797678 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs150761350 | chr2:113797712-113797713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs77516439 | chr2:113797741-113797742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528548602 | chr2:113797761-113797762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2862775 | chr2:113797762-113797763 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs13392105 | chr2:113797766-113797767 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs549026167 | chr2:113797779-113797780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556428559 | chr2:113797819-113797820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ocular motor apraxia | 21572526 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Idiopathic chronic pancreatitis | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Maculopathy | 20981449 | CNVD |
Nephronophthisis | 22470819 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113765600-113797400 | Weak transcription | Gastric | stomach |
2 | chr2:113795800-113797800 | Enhancers | Stomach Mucosa | stomach |
3 | chr2:113796200-113797600 | Enhancers | Pancreas | Pancrea |
4 | chr2:113796400-113796800 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
5 | chr2:113796400-113798000 | Enhancers | Liver | Liver |
6 | chr2:113796600-113796800 | Enhancers | Fetal Intestine Small | intestine |
7 | chr2:113796600-113798000 | Enhancers | Fetal Intestine Large | intestine |
8 | chr2:113796800-113797200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr2:113796800-113797400 | Enhancers | HepG2 | liver |
10 | chr2:113796800-113797600 | Enhancers | Fetal Lung | lung |
11 | chr2:113797400-113797600 | Enhancers | Gastric | stomach |
12 | chr2:113797600-113797800 | Enhancers | Fetal Intestine Small | intestine |
13 | chr2:113797600-113798600 | Weak transcription | Gastric | stomach |
14 | chr2:113797800-113799800 | Weak transcription | Stomach Mucosa | stomach |
15 | chr2:113798600-113798800 | Enhancers | Gastric | stomach |
16 | chr2:113804600-113805400 | Enhancers | Fetal Intestine Large | intestine |
17 | chr2:113804600-113805400 | Enhancers | Fetal Intestine Small | intestine |
18 | chr2:113805400-113805600 | Weak transcription | Fetal Intestine Small | intestine |
19 | chr2:113805400-113805800 | Weak transcription | Fetal Intestine Large | intestine |
20 | chr2:113805600-113806000 | Enhancers | Fetal Intestine Small | intestine |
21 | chr2:113805800-113806000 | Enhancers | Fetal Intestine Large | intestine |
22 | chr2:113806000-113808600 | Weak transcription | Fetal Intestine Large | intestine |
23 | chr2:113806000-113809000 | Weak transcription | Fetal Intestine Small | intestine |